intracellulartherapies.com (ITCI): Projected Sales Volume

Symbol and logo of brand Intra-Cellular Therapies Inc. (ITCI)

Intra-Cellular Therapies (ITCI) complies with basic environmental waste disposal standards. The company's sales volume target on the GURU.Markets chart shows that the 0.68 metric serves as the target level. Revenue growth is driven by new Caplyta indications and pipeline expansion. Dominance in the antipsychotic segment is supported by strong patent protection and physician trust, which limits the expansion of new players.

Company Projected Revenue: intracellulartherapies.com (ITCI) for 07/04/2022 - 04/13/2025

Analytical breakdowns for Intra-Cellular Therapies

General company analysis:Intra-Cellular Therapies Inc.
Product sample of Intra-Cellular Therapies

Monitoring leading indicators is critical for capital protection amid volatility. This metric aggregates market expectations for future inflows, replacing static reporting with a dynamic revenue forecast. By analyzing the future sales trajectory of a company, an investor determines the stability of fundamental trends. For Intra-Cellular Therapies (ITCI), this indicator reflects the commercial potential of its key drug. A declining curve signals increasing pressure from generics and patent risks.

Analysis of competing companies

Company Future Sales Volume BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Company Future Revenue|Company Projected Revenue Regencell RGC|Company Projected Revenue Volume AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Projected Sales Volume|XENE - Projected Sales Volume|VKTX: Projected Sales Volume|Company Expected Revenue SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Projected Sales Volume|DNLI: Company Future Revenue|Company Projected Revenue harmonybiosciences.com (HRMY)|Biohaven - Company Revenue Forecast|Projected Sales Volume AMLX (amylyx.com)|Trevi Pharma (TRVI) - Company Expected Sales Volume|Praxis Corp - Projected Sales Volume|Anavex Corp (AVXL) - Company Future Sales Volume|CBLL: Projected Sales Volume|Prothena Biosciences - Company Future Revenue|ALEC (alector.com) - Projected Sales Volume|Company Revenue Forecast ANNX (Annexon Biosciences)|Company Projected Revenue Omeros Corporation (OMER)|Neurogene Corp - Company Revenue Forecast|Company Projected Revenue AC Immune S.A. ACIU|Company Future Sales Voyager Therapeutics (VYGR)|Neumora - Projected Sales Volume|Company Expected Revenue SCLX|Tevogen Bio Inc. (TVGN) - Company Projected Revenue|Company Revenue Forecast ACOG|CGTX (cogrx.com) - Projected Sales Volume|Company Future Sales Volume inhibikase.com (IKT)|Company Projected Revenue Cassava Sciences Inc (SAVA)|Company Future Sales Assertio|Projected Sales Volume COYA (Coya Therapeutics, Inc.)|Company Projected Revenue Volume VTGN (VistaGen Therapeutics Inc)|OVID: Company Future Sales Volume|ABOS: Company Projected Revenue|CervoMed (CRVO) - Company Projected Revenue|Company Expected Sales Volume Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Projected Sales Volume|Company Revenue Forecast PEPG (PepGen)|Company Future Sales Volume JUNS (Jupiter Neurosciences, Inc.)|Projected Sales Volume relmada.com (RLMD)|Company Projected Revenue Annovis Bio Corp ANVS|GRCE: Company Revenue Forecast|AIFF - Company Projected Revenue|KLTO (anewmeds.com) - Company Revenue Forecast|NRSN (NeuroSense Therapeutics Ltd.) - Company Future Sales Volume|revivapharma.com - Company Future Revenue|MTVA (metaviatx.com) - Projected Sales Volume|NRXS: Company Future Revenue|Projected Sales Volume HSDT|PASG - Company Expected Sales Volume|Projected Sales Volume NEUP (Neuphoria Therapeutics)|NERV: Company Revenue Forecast|ATHA: Company Future Sales Volume|Addex Therapeutics Ltd - Company Projected Revenue Volume|Alzamend Neuro, Inc. (ALZN) - Company Projected Revenue|CYCN (Cyclerion Therapeutics Inc.) - Company Projected Revenue|Company Future Sales Volume PTIX|KTTA: Company Future Revenue|Company Future Sales Volume CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Company Future Revenue|Company Projected Revenue Brainstorm Cell Therapeutics, Inc. BCLI|Company Future Revenue CARA|chromocell.com - Projected Sales Volume|Company Expected Revenue ELYM|Longboard (LBPH) - Company Projected Revenue|Marinus Pharmaceuticals Inc - Company Future Revenue|Company Future Sales Volume NKGN|NeuroBo - Company Expected Revenue|Company Projected Revenue Sage Therapeutics, Inc (SAGE)|Company Future Sales Volume Synaptogenix SNPX|Trevena, Inc. - Company Future Sales Volume|VIGL: Company Revenue Forecast|WENA: Company Future Sales Volume|Company Expected Sales Volume Cerevel Therapeutics